On the contrary to CRC, those immune-related signaling pathways (TNF-α signaling via NF-κB, interferon α/γ responses, and allograft rejection) were significantly upregulated in both polyp or adenoma patients (Additional file 1: Fig. S3). The gene discussed is TNF; the disease is colorectal carcinoma.